Beach Medical Wellness - North Augusta
220 Edgefield Road · North Augusta, SC 29841
4.9(315 Google reviews · 12 in past year)
Glow Aesthetics and Wellness · 104 Walnut Lane · North Augusta, SC 29860
5.0· 52 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Glow Aesthetics and Wellness is a medical weight-loss and aesthetics practice in North Augusta, South Carolina. Its website lists medical weight loss alongside aesthetic services such as Glowtox and prescription skin care, and introduces owner Linsey Caines, a board-certified family nurse practitioner with more than five years of experience, and a second board-certified family nurse practitioner, Chandler. On Google it has a 5.0-star rating across 52 reviews dating back to 2023, 27 in the past year; reviewers most often mention the staff, results and a caring approach.
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Counts computed by RetaMaps from public Google reviews; most recent review 2026-07-14. Read the reviews themselves on the practice's Google listing.
Rated ★5.0 across 52 Google reviews. Of the 49 reviews we analyzed, 49 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
No negative reviews among those we analyzed.
Gabe M.★★★★★2026-07-13Very Happy
Alicia B.★★★★★2026-02-25⭐️⭐️⭐️⭐️⭐️ Glow Wellness has truly helped me feel like me again. From the very first visit, the ladies there have been so helpful, supportive, and genuinely caring. Every appointment feels encouraging and comfortable, and you can tell they truly want the best for their clients. I appreciate them more than I can say and highly recommend Glow Wellness to anyone looking to feel their best again. Whether it’s weight loss, hormones, or injections they have it all. And willing to help you in any way.
Anonymous A.★★★★★2026-02-24I have gone to glow a few times and have had the most amazing experience every time. They always make you feel so welcomed.
Marissa L.★★★★★2026-02-16⭐️⭐️⭐️⭐️⭐️ Without a doubt, the BEST staff and treatment. Glow has the most welcoming environment and those ladies know their stuff. I have been going to Glow for a couple years now and they always listen and take the time to understand exactly what you want before even doing anything to you. I get Botox and a lip flip done here and it last and I love the results every single time!!
Carrie D.★★★★★2026-02-16Lindsey and her team are amazing! I’m at the end of month 3 of my weight loss journey with compound GLP1. I’ve lost 30lbs! Can’t wait to loose another 30 more!
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
220 Edgefield Road · North Augusta, SC 29841
4.9(315 Google reviews · 12 in past year)
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs